FDA Inspection 1272883 — EnduroMed

EnduroMed — FEI 3025513979

The FDA completed an inspection of EnduroMed on Jun 17, 2025 in Brookfield, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 17, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Brookfield, WI (United States)

Citations

IDCFRDescription
1233821 CFR 1271.180(b)Review and approval-responsible person

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.